Business Update30 March 2026 at 12:21 pm
Prism Medico and Pharmacy Ltd: No Undisclosed Price-Sensitive Information, Movement Market Driven
AI Summary
Prism Medico and Pharmacy Ltd clarified a significant movement in their security price at the stock exchange, stating that all material information has been disclosed in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company highlights that the price movement is due to market conditions and speculation, over which they have no control. The promoter and KMPs have not dealt with any securities in the recent past. The company reiterates its commitment to informing stock exchanges about any price-sensitive information as required.
Key Highlights
- Prism Medico and Pharmacy Ltd have disclosed all material information in accordance with SEBI regulations.
- The significant movement in security price is due to market conditions and speculation.
- The management has no control over the price movement.
- Neither the promoter nor KMPs have dealt with any securities in the recent past.
- The company reiterates its commitment to informing stock exchanges about any price-sensitive information.